GPX4 and hepatocellular carcinoma: Additionally, CRISPR-based loss-of-function genetic screens identified phosphoseryl-tRNA kinase (PSTK) as a regulator of ferroptosis by inactivating GPX4 and disrupting glutathione metabolism in HCC (Chen Y. et al., 2022).